Jessica S Merlin1, Andrew O Westfall, Sonya L Heath, Burel R Goodin, Jesse C Stewart, Robert E Sorge, Jarred Younger. 1. *Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL; †Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, AL; ‡Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL; §Department of Psychology, University of Alabama at Birmingham, Birmingham, AL; ‖Division of Pain Medicine, University of Alabama at Birmingham, Birmingham, AL; and ¶Department of Psychology, Indiana University-Purdue University Indianapolis (IUPUI), Indianapolis, IN.
Abstract
BACKGROUND: The pathophysiology of chronic pain experienced by people living with HIV (PLWH) in the current antiretroviral treatment era is poorly understood. We sought to investigate the relationship between inflammation and chronic pain in PLWH. We hypothesized that, among PLWH who have undetectable HIV viral loads, those with chronic multisite pain (CMP) would have higher levels of circulating pain-related inflammatory markers than those without chronic pain. SETTING: This study was conducted at the University of Alabama at Birmingham's Center for AIDS Research Network of Integrated Clinical System site. METHODS: We compared inflammatory markers in 70 PLWH with CMP and 70 PLWH without chronic pain. Custom multiplex human inflammatory assays were completed on banked plasma specimens to measure cytokines commonly associated with chronic inflammatory pain: interleukin 1β (IL-1β), eotaxin, IL-15, IL-6, tumor necrosis factor α, and leptin. Logistic regression models were built using group status (CMP vs no pain) as the outcome variable, with each cytokine as independent variables and age, sex, substance use, and prescribed opioid medications as covariates. RESULTS: Participants were mostly men (71%); 53% were 50 years or older. The most common sites of pain were low back (86%), hands/feet (81%), and knee (66%). Median CD4 T-cell count was 676 cells per milliliter. IL-1β was significantly higher in the CMP group than in the individuals without chronic pain (odds ratio: 1.35, 95% confidence interval: 1.01 to 1.82, P < 0.05). Eotaxin, IL-15, IL-6, tumor necrosis factor α, and leptin were not significantly different between groups. CONCLUSIONS: We found that PLWH who also have CMP have significantly higher levels of IL-1β than PLWH who do not have any pain. Future work on the role of IL-1β on chronic pain pathogenesis in this population may inform novel approaches to chronic pain management.
BACKGROUND: The pathophysiology of chronic pain experienced by people living with HIV (PLWH) in the current antiretroviral treatment era is poorly understood. We sought to investigate the relationship between inflammation and chronic pain in PLWH. We hypothesized that, among PLWH who have undetectable HIV viral loads, those with chronic multisite pain (CMP) would have higher levels of circulating pain-related inflammatory markers than those without chronic pain. SETTING: This study was conducted at the University of Alabama at Birmingham's Center for AIDS Research Network of Integrated Clinical System site. METHODS: We compared inflammatory markers in 70 PLWH with CMP and 70 PLWH without chronic pain. Custom multiplex human inflammatory assays were completed on banked plasma specimens to measure cytokines commonly associated with chronic inflammatory pain: interleukin 1β (IL-1β), eotaxin, IL-15, IL-6, tumor necrosis factor α, and leptin. Logistic regression models were built using group status (CMP vs no pain) as the outcome variable, with each cytokine as independent variables and age, sex, substance use, and prescribed opioid medications as covariates. RESULTS:Participants were mostly men (71%); 53% were 50 years or older. The most common sites of pain were low back (86%), hands/feet (81%), and knee (66%). Median CD4 T-cell count was 676 cells per milliliter. IL-1β was significantly higher in the CMP group than in the individuals without chronic pain (odds ratio: 1.35, 95% confidence interval: 1.01 to 1.82, P < 0.05). Eotaxin, IL-15, IL-6, tumor necrosis factor α, and leptin were not significantly different between groups. CONCLUSIONS: We found that PLWH who also have CMP have significantly higher levels of IL-1β than PLWH who do not have any pain. Future work on the role of IL-1β on chronic pain pathogenesis in this population may inform novel approaches to chronic pain management.
Authors: Jessica S Merlin; Andrew O Westfall; Eric Chamot; Michael Saag; Melonie Walcott; Christine Ritchie; Stefan Kertesz Journal: AIDS Res Hum Retroviruses Date: 2015-03-12 Impact factor: 2.205
Authors: Michael Von Korff; Ann I Scher; Charles Helmick; Olivia Carter-Pokras; David W Dodick; Joseph Goulet; Robin Hamill-Ruth; Linda LeResche; Linda Porter; Raymond Tait; Gregory Terman; Christin Veasley; Sean Mackey Journal: J Pain Date: 2016-07-01 Impact factor: 5.820
Authors: Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi; Theodore J Cicero; Kiyomi Tsuyuki; Catherine L O'Grady Journal: AIDS Patient Care STDS Date: 2014-07-01 Impact factor: 5.078
Authors: Erin E Krebs; Karl A Lorenz; Matthew J Bair; Teresa M Damush; Jingwei Wu; Jason M Sutherland; Steven M Asch; Kurt Kroenke Journal: J Gen Intern Med Date: 2009-05-06 Impact factor: 5.128
Authors: Heather M Derry-Vick; Carrie D Johnston; Mark Brennan-Ing; Chelsie O Burchett; Nina Glesby; Yuan-Shan Zhu; Eugenia L Siegler; Marshall J Glesby Journal: Psychosom Med Date: 2022-07-27 Impact factor: 3.864
Authors: Jessica S Merlin; Dustin Long; William C Becker; Edward R Cachay; Katerina A Christopoulos; Kasey Claborn; Heidi M Crane; E Jennifer Edelman; Richard Harding; Stefan G Kertesz; Jane M Liebschutz; W Christopher Mathews; Michael J Mugavero; Sonia Napravnik; Connall C OʼCleirigh; Michael S Saag; Joanna L Starrels; Robert Gross Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: Alexandra Y Soare; Natasha D Durham; Ramya Gopal; Benjamin Tweel; Kevin W Hoffman; Julia A Brown; Megan O'Brien; Nina Bhardwaj; Jean K Lim; Benjamin K Chen; Talia H Swartz Journal: J Virol Date: 2018-12-10 Impact factor: 5.103
Authors: Antonia L Wadley; Romy Parker; Vanessa A Mukhuba; Andani Ratshinanga; Zipho Zwane; Peter R Kamerman Journal: Afr J Prim Health Care Fam Med Date: 2022-01-11
Authors: Whitney Scott; Chinar Arkuter; Kitty Kioskli; Harriet Kemp; Lance M McCracken; Andrew S C Rice; Amanda C de C Williams Journal: Pain Date: 2018-12 Impact factor: 6.961